What does DESMEDT JEF do?

DESMEDT JEF is a veterinary practice in Oudsbergen. Private Limited, started on 22 November 2007, 1 establishment.

What is the address of DESMEDT JEF?

The registered office of DESMEDT JEF is located at Plockroy 7, 3670 Oudsbergen.

Is DESMEDT JEF still active?

Yes. According to the CBE (29 October 2026) DESMEDT JEF is active, legal situation “Normale toestand”, started on 22 November 2007.

Is DESMEDT JEF registered on Peppol?

Yes, DESMEDT JEF is registered on the Peppol network with ID 0208:0893644073.

What is the enterprise number of DESMEDT JEF?

The enterprise number of DESMEDT JEF is BE0893644073.

When was DESMEDT JEF founded?

DESMEDT JEF was founded on 22 November 2007.

Who are the directors of DESMEDT JEF?

According to the 2025 annual accounts, the directors of DESMEDT JEF are: Jef August C Desmedt, ECG Ambulatory Care BV.

Is DESMEDT JEF a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 November 2007; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DESMEDT JEF make in 2025?

DESMEDT JEF recorded a loss after taxes of € 103,527 in financial year 2025.

What is the revenue of DESMEDT JEF?

In its most recent annual accounts (2025), DESMEDT JEF reported revenue of € 1,478,344.

How much does an employee at DESMEDT JEF earn?

The average wage cost per full-time employee at DESMEDT JEF was € 34,400 in 2025: staff costs of € 189,358 for 5.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does DESMEDT JEF have?

According to the 2025 annual accounts, DESMEDT JEF has 5.5 full-time equivalents (FTE).

DESMEDT JEF (Private Limited) - Oudsbergen - BE0893644073

Dossier DESMEDT JEF, printed on 29 October 2026 from databakkes.be/en/0893644073/desmedt-jef. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DESMEDT JEF from Oudsbergen, company number BE0893644073, closed financial year 2025 with a result of € -103,527 after tax. For that financial year DESMEDT JEF recorded revenue of € 1.5 million and equity of € 135,263. Compared with financial year 2024, the result moved from € 42,473 to € -103,527. The company made a loss. The buffer shrank hard: equity is 69 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Shrank hard

€ 135,263

▼ 69% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -103,527

▼ still € 42,473 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 75,318

▼ 61% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 122,863.

People and assets in 2025

Full-time equivalents

5.5

▲ 1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 189,358

▲ 15% vs 2024

€ 34,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 13,798

▼ 64% vs 2024

Of which on lease € 7,079.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 13,712

▼ 24% vs 2024

€ 4,520 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 177,035

▲ 257% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 33,342

▲ 29% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	-	-	€ 1,379,941 Revenue 2024: € 1,379,941 First fiscal year in the series	€ 1,478,344 Revenue 2025: € 1,478,344 ▲ 7% vs 2024 (€ 1,379,941) Favourable step	▲ 7%
Gross margin	€ 797,319 Gross margin 2022: € 797,319 First fiscal year in the series	€ 2,015,805 Gross margin 2023: € 2,015,805 ▲ 153% vs 2022 (€ 797,319) Favourable step	€ 297,677 Gross margin 2024: € 297,677 ▼ 85% vs 2023 (€ 2,015,805) Unfavourable step	€ 201,166 Gross margin 2025: € 201,166 ▼ 32% vs 2024 (€ 297,677) Unfavourable step	▼ 32%
Profit after taxes	€ 544,383 Profit after taxes 2022: € 544,383 First fiscal year in the series	€ 475,788 Profit after taxes 2023: € 475,788 ▼ 13% vs 2022 (€ 544,383) Unfavourable step	€ 42,473 Profit after taxes 2024: € 42,473 ▼ 91% vs 2023 (€ 475,788) Unfavourable step	€ -103,527 Profit after taxes 2025: € -103,527 ▼ € 146,001 vs 2024 (€ 42,473) Unfavourable step	▼ € 146,001
Equity	€ 2,123,827 Equity 2022: € 2,123,827 First fiscal year in the series	€ 496,317 Equity 2023: € 496,317 ▼ 77% vs 2022 (€ 2,123,827) Unfavourable step	€ 438,790 Equity 2024: € 438,790 ▼ 12% vs 2023 (€ 496,317) Unfavourable step	€ 135,263 Equity 2025: € 135,263 ▼ 69% vs 2024 (€ 438,790) Unfavourable step	▼ 69%
Total debts	€ 141,165 Total debts 2022: € 141,165 First fiscal year in the series	€ 1,538,257 Total debts 2023: € 1,538,257 ▲ € 1.4 million vs 2022 (€ 141,165) Unfavourable step	€ 228,509 Total debts 2024: € 228,509 ▼ 85% vs 2023 (€ 1,538,257) Favourable step	€ 427,474 Total debts 2025: € 427,474 ▲ 87% vs 2024 (€ 228,509) Unfavourable step	▲ 87%
Cash	€ 1,299,560 Cash 2022: € 1,299,560 First fiscal year in the series	€ 510,671 Cash 2023: € 510,671 ▼ 61% vs 2022 (€ 1,299,560) Unfavourable step	€ 194,543 Cash 2024: € 194,543 ▼ 62% vs 2023 (€ 510,671) Unfavourable step	€ 75,318 Cash 2025: € 75,318 ▼ 61% vs 2024 (€ 194,543) Unfavourable step	▼ 61%
Retained profit	€ 2,111,427 Retained profit 2022: € 2,111,427 First fiscal year in the series	€ 483,917 Retained profit 2023: € 483,917 ▼ 77% vs 2022 (€ 2,111,427) Unfavourable step	€ 426,390 Retained profit 2024: € 426,390 ▼ 12% vs 2023 (€ 483,917) Unfavourable step	€ 122,863 Retained profit 2025: € 122,863 ▼ 71% vs 2024 (€ 426,390) Unfavourable step	▼ 71%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 2,103,298 Dividend 2023: € 2,103,298 Unchanged (€ 0) Unchanged	€ 100,000 Dividend 2024: € 100,000 ▼ 95% vs 2023 (€ 2,103,298) Unchanged	€ 200,000 Dividend 2025: € 200,000 ▲ 100% vs 2024 (€ 100,000) Unchanged	▲ 100%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 22,223 Bank debt 2023: € 22,223 Unchanged (€ 0) Unfavourable step	€ 18,053 Bank debt 2024: € 18,053 ▼ 19% vs 2023 (€ 22,223) Favourable step	€ 13,712 Bank debt 2025: € 13,712 ▼ 24% vs 2024 (€ 18,053) Favourable step	▼ 24%
Balance sheet total	€ 3,232,737 Balance sheet total 2022: € 3,232,737 First fiscal year in the series	€ 2,034,574 Balance sheet total 2023: € 2,034,574 ▼ 37% vs 2022 (€ 3,232,737) Unchanged	€ 667,300 Balance sheet total 2024: € 667,300 ▼ 67% vs 2023 (€ 2,034,574) Unchanged	€ 562,737 Balance sheet total 2025: € 562,737 ▼ 16% vs 2024 (€ 667,300) Unchanged	▼ 16%
Employees (FTE)	2.6 Employees (FTE) 2022: 2.6 First fiscal year in the series	4 Employees (FTE) 2023: 4 ▲ 1.4 vs 2022 (2.6) Unchanged	4.5 Employees (FTE) 2024: 4.5 ▲ 0.5 vs 2023 (4) Unchanged	5.5 Employees (FTE) 2025: 5.5 ▲ 1 vs 2024 (4.5) Unchanged	▲ 1

Key figures of DESMEDT JEF, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DESMEDT JEF?

What happened at DESMEDT JEF in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: loss of € 103,527 (▼ € 146,001 vs 2024). Source: NBB ↗
2023 ECG Ambulatory Care BV became a director. NBB
2020 Jef August C Desmedt became a director. NBB
Nov 22, 2007 New establishment in Oudsbergen. KBO
Nov 22, 2007 Start of the company according to the CBE. KBO

In short

From € 544,383 profit in 2022 to € 103,527 loss in 2025.

Paid € 356,103 in corporate taxes since 2022.

Best year ever: 2022, with € 544,383 profit.

On average € 36,600 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

ECG Ambulatory Care 100%

The stake of ECG Ambulatory Care comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

DESMEDT JEF

Behind DESMEDT JEF are Jef August C Desmedt and ECG Ambulatory Care BV. The shares are held by ECG Ambulatory Care (100%).

Directors

According to the 2025 annual accounts

Jef August C Desmedt

Director

Also active at: JLDB

since 2020

ECG Ambulatory Care BV

Director · represented by Jonathan Mommer

Also active at: ECG Clinics, Michèle Clarysse, DAP SEIFERT CHARLOTTE, EF EQUINE LAMENESS INVESTIGATION & PARTNERS, ECG Ambulatory Care

since 2023

Shareholders

ECG Ambulatory Care

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Plockroy 7

3670 Oudsbergen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

DE JOLIE

€ 64,459 gross margin · 2025

JLDB same network

€ 272,821 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0893.644.073
VAT number: BE 0893.644.073
Registered office: Plockroy 7, 3670 Oudsbergen
Names & denominations: DESMEDT JEF
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 22 November 2007
Peppol: Active · Active since 18 Sept 2024
Activities · NACE: Veterinaire diensten

View on CBE Public ↗ Annual accounts (NBB) ↗